Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Reproductive BioMedicine Online
- Does zona pellucida thickness influence the fertilization rate?.Hum. Reprod. 1995; 10: 1189-1193
- ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria.Hum. Reprod. 2011; 26: 1616-1624
- Comparing intracytoplasmic sperm injection and in vitro fertilization in patients with single oocyte retrieval.Fertil. Steril. 2007; 87: 515-518
- Defining a poor responder in in vitro fertilization.Fertil. Steril. 2004; 82: 488-490
- Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.Hum. Reprod. 2004; 19: 1544-1547
- Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF).Hum. Fertil. (Camb.). 2011; 14: 230-245
- Assisted conception following poor ovarian response to gonadotrophin stimulation.Br. J. Obstet. Gynaecol. 1997; 104: 521-527
- Do age and extended culture affect the architecture of the zona pellucida of human oocytes and embryos?.Zygote. 2006; 14: 39-44
- A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.Fertil. Steril. 2004; 81: 1247-1253
- How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.Fertil. Steril. 2009; 91: 749-766
- Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved?.J. Assist. Reprod. Genet. 2011; 28: 911-915
- Intracytoplasmic sperm injection as a routine indication in low responder patients.Hum. Reprod. 1998; 13: 2126-2129
- Is the zona pellucida thickness of metaphase-II oocytes in an IVF/ICSI program influenced by the patient’s age?.Gynecol. Obstet. Invest. 2001; 52: 55-59
- Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles.Fertil. Steril. 2010; 93: 96-100
- The poor responder in IVF: is the prognosis always poor? A systematic review.Hum. Reprod. Update. 2012; 18: 1-11
Pandian, Z., Mctavish, A.R., Aucott, L., Hamilton, M.P., Bhattacharya, S., 2010. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst. Rev., CD004379.
- A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?.Fertil. Steril. 2011; 96 (1058–61.e7)
- The probability of successful IVF outcome after poor ovarian response.Acta Obstet. Gynecol. Scand. 2007; 86: 457-461
- Birth after the reimplantation of a human embryo.Lancet. 1978; 2: 366
- Clinical management of low ovarian response to stimulation for IVF: a systematic review.Hum. Reprod. Update. 2003; 9: 61-76
- Ovarian reserve, female age and the chance for successful pregnancy.Minerva Ginecol. 2003; 55: 399-406
- High fertilization and implantation rates after intracytoplasmic sperm injection.Hum. Reprod. 1993; 8: 1061-1066
- An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles.Fertil. Steril. 2005; 83: 1384-1390
Dr Ettie Maman is a senior physician in the IVF unit, Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Aviv University, Israel. She graduated from Ben Gurion University, School of Medicine in Beer Sheba, Israel, in 1998. She completed her residency in obstetrics and gynaecology at the Department of Obstetrics and Gynecology, Sheba Medical Center. She worked as a research fellow at the Samuel Lunenfeld Research Institute, Mt Sinai Hospital, Toronto, Ontario, Canada. She joined the Sheba Medical Center IVF programme in 2006 and her research interests are related to infertility, in-vitro maturation and stem cells.